Role of NO-synthases and cyclooxygenases in the hyperreactivity of male rabbit carotid artery to testosterone under experimental diabetes

Pharmacological Research

Volumn 61, Issue 1, 2010, Pages 62-70

  Marrachelli, Vannina G ^a   Miranda, Francisco J ^a   Centeno, José M ^a   Salom, Juan B ^a,b   Torregrosa, Germán ^a,b   Jover Mengual, Teresa ^a   Pérez, Antonio M ^a   Moro, Maria A ^c   Alborch, Enrique ^a,b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Carotid artery; Cyclooxygenases; Diabetes; Nitric oxide synthases; Testosterone

Indexed keywords

CALCIUM CHLORIDE; CALCIUM ION; CYCLOOXYGENASE 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INDUCIBLE NITRIC OXIDE SYNTHASE; PROSTACYCLIN; TESTOSTERONE; THROMBOXANE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CAROTID ARTERY; CONTROLLED STUDY; DIABETES MELLITUS; EXTRACELLULAR CALCIUM; HORMONE ACTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PROTEIN FUNCTION; RABBIT;

ANIMALS; APAMIN; BLOOD GLUCOSE; BLOTTING, WESTERN; CALCIUM; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CHARYBDOTOXIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; IMMUNOENZYME TECHNIQUES; INDOMETHACIN; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; NITROARGININE; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; RABBITS; TESTOSTERONE; THROMBOXANE A2; VASODILATION;

EID: 72749113992     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2009.06.008     Document Type: Article

References (41)

1. Grant J.F., Hicks N., Taylor A.W., Chittleborough C.R., and Phillips P.J. The North West Adelaide Health Study Team. Gender-specific epidemiology of diabetes: a representative cross-sectional study. Int J Equity Health 8 (2009) 6
2. Mulligan T., Frick M.F., Zuraw Q.C., Stemhagen A., and McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract 60 (2006) 762-769
3. Stirban A., Rösen P., and Tschoepe D. Complications of type 1 diabetes: new molecular findings. Mt Sinai J Med 75 (2008) 328-351
4. Reckelhoff J.F., Zhang H., Srivastava K., and Granger J.P. Gender differences in hypertension in spontaneously hypertensive rats: role of androgens and androgen receptor. Hypertension 34 (1999) 920-923
5. Pugh P.J., Jones R.D., West J.N., Jones T.H., and Channer K.S. Testosterone treatment for men with chronic heart failure. Heart 90 (2004) 446-447
6. Kapoor D., Malkin C.J., Channer K.S., and Jones T.H. Androgens, insulin resistance and vascular disease in men. Clin Endocrinol (Oxf) 63 (2005) 239-250
7. Upmacis R.K., Deeb R.S., and Hajjar D.P. Oxidative alterations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat 80 (2006) 1-14
8. Moncada S., Higgs A., and Furchgott R. International union of pharmacology nomenclature in nitric oxide research. Pharmacol Rev 49 (1997) 137-142
9. Foudi N., Louedec L., Cachina T., Brink C., and Norel X. Selective cyclooxygenase-2 inhibition directly increases human vascular reactivity to norepinephrine during acute inflammation. Cardiovasc Res 81 (2009) 269-277
10. Dias Pereira P., Lopes C.C., Matos A.J., Santos M., Gärtner F., Medeiros R., et al. COX-2 expression in canine normal and neoplastic mammary gland. J Comp Pathol 140 (2009) 247-253
11. 2α mediates endothelium-dependent contractions in the aortae of hamsters with increased impact during aging. Circ Res 104 (2009) 228-235
12. Jones R.D., Pugh P.J., Jones T.H., and Channer K.S. The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action?. Br J Pharmacol 138 (2003) 733-744
13. Jones R.D., Hugh Jones T., and Channer K.S. The influence of testosterone upon vascular reactivity. Eur J Endocrinol 151 (2004) 29-37
14. Seyrek M., Yildiz O., Ulusoy H.B., and Yildirim V. Testosterone relaxes isolated human radial artery by potassium channel opening action. J Pharmacol Sci 103 (2007) 309-316
15. Busse R., Edwards G., Félétou M., Fleming I., Vanhoutte P.M., and Weston A.H. EDHF: bringing the concepts together. Trends Pharmacol Sci 23 (2002) 374-380
16. Jeppesen L.L., Jørgensen H.S., Nakayama H., Raaschou H.O., Olsen T.S., and Winther K. Decreased serum testosterone in men with acute ischemic stroke. Arterioscler Thromb Vasc Biol 16 (1996) 749-754
17. Miner M.M., and Seftel A.D. Centrally acting mechanisms for the treatment of male sexual dysfunction. Urol Clin North Am 34 (2007) 483-496
18. Centol I., López-Blanco F., Deniz A., Benítez L., Marrero-Arencibia I., Fanjul L., et al. Serum androgen levels after streptozotocin administration in the male rat. Rev Esp Fisiol 44 (1988) 31-34
19. Miranda F.J., Alabadí J.A., Llorens S., Ruiz de Apodaca R.F., Centeno J.M., and Alborch E. Influence of experimental diabetes on regulatory mechanisms of vascular response of rabbit carotid artery to acetylcholine. Life Sci 66 (2000) 2071-2080
20. Malkin C.J., Jones R.D., Jones T.H., and Channer K.S. Effect of testosterone on ex vivo vascular reactivity in man. Clin Sci (Lond) 111 (2006) 265-274
21. I and tension in rabbit coronary arteries: by opening voltage dependent potassium channels. Yonsei Med J 44 (2003) 1027-1033
22. Chou T.M., Sudhir K., Hutchison S.J., Ko E., Amidon T.M., Collins P., et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation 94 (1996) 2614-2619
23. Tep-areenan P., Kendall D.A., and Randall M.D. Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels. Br J Pharmacol 135 (2002) 735-740
24. Zanetti M., Sato J., Katusic Z.S., and O'Brien T. Gene transfer of endothelial nitric oxide synthase alters endothelium-dependent relaxations in aortas from diabetic rabbits. Diabetologia 43 (2000) 340-347
25. Nagareddy P.R., Xia Z., MacLeod K.M., and McNeill J.H. N-acetylcysteine prevents nitrosative stress-associated depression of blood pressure and heart rate in streptozotocin diabetic rats. J Cardiovasc Pharmacol 47 (2006) 513-520
26. Weissman B.A., Sottas C.M., Zhou P., Iadecola C., and Hardy M.P. Testosterone production in mice lacking inducible nitric oxide synthase expression is sensitive to restraint stress. Am J Physiol Endocrinol Metab 292 (2007) E615-E620
27. Lafuente N., Matesanz N., Azcutia V., Romacho T., Nevado J., Rodríguez-Mañas L., et al. The deleterious effect of high concentrations of D-glucose requires pro-inflammatory preconditioning. J Hypertens 26 (2008) 478-485
28. Bishop-Bailey D., Pepper J.R., Haddad E.B., Newton R., Larkin S.W., and Mitchell J.A. Induction of cyclooxygenase-2 in human saphenous vein and internal mammary artery. Arterioscler Thromb Vasc Biol 17 (1997) 1644-1648
29. Caughey G.E., Cleland L.G., Penglis P.S., Gamble J.R., and James M.J. Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2. J Immunol 167 (2001) 2831-2838
30. De Meyer G.R., and Herman A.G. Vascular endothelial dysfunction. Prog Cardiovasc Dis 39 (1997) 325-342
31. Parente L., and Perretti M. Advances in the pathophysiology of constitutive and inducible cyclooxygenases: two enzymes in the spotlight. Biochem Pharmacol 65 (2003) 153-159
32. Sobey C.G. Potassium channel function in vascular disease. Arterioscler ThrombVasc Biol 21 (2001) 28-38
33. Tanaka Y., Koike K., and Toro L. MaxiK channel roles in blood vessel relaxations induced by endothelium-derived relaxing factors and their molecular mechanisms. J Smooth Muscle Res 40 (2004) 125-153
34. Mayhan W.G., Mayhan J.F., Sun H., and Patel K.P. In vivo properties of potassium channels in cerebral blood vessels during diabetes mellitus. Microcirculation 11 (2004) 605-613
35. Yue P., Chatterjee K., Beale C., Poole-Wilson P.A., and Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation 91 (1995) 1154-1160
36. + channels by high glucose. Circ Res 99 (2006) 607-616
37. 2+ channels. Biochem Biophys Res Commun 318 (2004) 503-506
38. 2+ entry mechanisms of arterial vasoconstriction by sex hormones. Clin Exp Pharmacol Physiol 26 (1999) 707-715
39. 2+ entry mechanisms of coronary vasoconstriction. Arterioscler Thromb Vasc Biol 19 (1999) 1034-1040
40. i during inhibition of coronary smooth muscle contraction by 17β-estradiol, progesterone, and testosterone. J Pharmacol Exp Ther 291 (1999) 44-52
41. Perusquía M., Hernández R., Morales M.A., Campos M.G., and Villalón C.M. Role of endothelium in the vasodilating effect of progestins and androgens on the rat thoracic aorta. Gen Pharmacol 27 (1996) 181-185